Fetal heart rate development during labour.


Journal

Biomedical engineering online
ISSN: 1475-925X
Titre abrégé: Biomed Eng Online
Pays: England
ID NLM: 101147518

Informations de publication

Date de publication:
16 Mar 2021
Historique:
received: 21 12 2020
accepted: 27 02 2021
entrez: 17 3 2021
pubmed: 18 3 2021
medline: 7 4 2021
Statut: epublish

Résumé

Fresh stillbirths (FSB) and very early neonatal deaths (VEND) are important global challenges with 2.6 million deaths annually. The vast majority of these deaths occur in low- and low-middle income countries. Assessment of the fetal well-being during pregnancy, labour, and birth is normally conducted by monitoring the fetal heart rate (FHR). The heart rate of newborns is reported to increase shortly after birth, but a corresponding trend in how FHR changes just before birth for normal and adverse outcomes has not been studied. In this work, we utilise FHR measurements collected from 3711 labours from a low and low-middle income country to study how the FHR changes towards the end of the labour. The FHR development is also studied in groups defined by the neonatal well-being 24 h after birth. A signal pre-processing method was applied to identify and remove time periods in the FHR signal where the signal is less trustworthy. We suggest an analysis framework to study the FHR development using the median FHR of all measured heart rates within a 10-min window. The FHR trend is found for labours with a normal outcome, neonates still admitted for observation and perinatal mortality, i.e. FSB and VEND. Finally, we study how the spread of the FHR changes over time during labour. When studying all labours, there is a drop in median FHR from 134 beats per minute (bpm) to 119 bpm the last 150 min before birth. The change in FHR was significant ([Formula: see text]) using Wilcoxon signed-rank test. A drop in median FHR as well as an increased spread in FHR is observed for all defined outcome groups in the same interval. A significant drop in FHR the last 150 min before birth is seen for all neonates with a normal outcome or still admitted to the NCU at 24 h after birth. The observed earlier and larger drop in the perinatal mortality group may indicate that they struggle to endure the physical strain of labour, and that an earlier intervention could potentially save lives. Due to the low amount of data in the perinatal mortality group, a larger dataset is required to validate the drop for this group.

Sections du résumé

BACKGROUND BACKGROUND
Fresh stillbirths (FSB) and very early neonatal deaths (VEND) are important global challenges with 2.6 million deaths annually. The vast majority of these deaths occur in low- and low-middle income countries. Assessment of the fetal well-being during pregnancy, labour, and birth is normally conducted by monitoring the fetal heart rate (FHR). The heart rate of newborns is reported to increase shortly after birth, but a corresponding trend in how FHR changes just before birth for normal and adverse outcomes has not been studied. In this work, we utilise FHR measurements collected from 3711 labours from a low and low-middle income country to study how the FHR changes towards the end of the labour. The FHR development is also studied in groups defined by the neonatal well-being 24 h after birth.
METHODS METHODS
A signal pre-processing method was applied to identify and remove time periods in the FHR signal where the signal is less trustworthy. We suggest an analysis framework to study the FHR development using the median FHR of all measured heart rates within a 10-min window. The FHR trend is found for labours with a normal outcome, neonates still admitted for observation and perinatal mortality, i.e. FSB and VEND. Finally, we study how the spread of the FHR changes over time during labour.
RESULTS RESULTS
When studying all labours, there is a drop in median FHR from 134 beats per minute (bpm) to 119 bpm the last 150 min before birth. The change in FHR was significant ([Formula: see text]) using Wilcoxon signed-rank test. A drop in median FHR as well as an increased spread in FHR is observed for all defined outcome groups in the same interval.
CONCLUSION CONCLUSIONS
A significant drop in FHR the last 150 min before birth is seen for all neonates with a normal outcome or still admitted to the NCU at 24 h after birth. The observed earlier and larger drop in the perinatal mortality group may indicate that they struggle to endure the physical strain of labour, and that an earlier intervention could potentially save lives. Due to the low amount of data in the perinatal mortality group, a larger dataset is required to validate the drop for this group.

Identifiants

pubmed: 33726745
doi: 10.1186/s12938-021-00861-z
pii: 10.1186/s12938-021-00861-z
pmc: PMC7962212
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Subventions

Organisme : GLOBVAC
ID : 228203

Références

Lancet Glob Health. 2016 Feb;4(2):e98-e108
pubmed: 26795602
Arch Dis Child Fetal Neonatal Ed. 2021 Jan 15;:
pubmed: 33452220
IEEE Trans Biomed Eng. 2009 Jun;56(6):1587-97
pubmed: 19237336
J Obstet Gynecol Neonatal Nurs. 2004 Jan-Feb;33(1):93-104
pubmed: 14971558
IEEE Trans Biomed Eng. 2010 Apr;57(4):771-9
pubmed: 20659819
IEEE Trans Biomed Eng. 2006 May;53(5):855-64
pubmed: 16686408
Gynecol Obstet Invest. 2013;75(2):101-8
pubmed: 23328351
BMC Med Inform Decis Mak. 2019 Dec 30;19(1):286
pubmed: 31888592
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:2606-2609
pubmed: 29060433
Lancet. 2016 Feb 6;387(10018):587-603
pubmed: 26794078
Int J Gynaecol Obstet. 2015 Oct;131(1):9-12
pubmed: 26433400
Am J Obstet Gynecol. 1993 Jan;168(1 Pt 1):63-6
pubmed: 8420351
Int J Gynaecol Obstet. 2015 Oct;131(1):13-24
pubmed: 26433401
Neonatology. 2016;110(3):231-7
pubmed: 27250761
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:3166-3169
pubmed: 29060570

Auteurs

Jarle Urdal (J)

Department of Electrical Engineering and Computer Science, University of Stavanger, Stavanger, Norway. jarle.urdal@uis.no.

Kjersti Engan (K)

Department of Electrical Engineering and Computer Science, University of Stavanger, Stavanger, Norway.

Trygve Eftestøl (T)

Department of Electrical Engineering and Computer Science, University of Stavanger, Stavanger, Norway.

Solveig H Haaland (SH)

Strategic Research, Laerdal Medical AS, Stavanger, Norway.

Benjamin Kamala (B)

Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.
Department of Obstetrics and Gynecology, Muhimbili National Hospital, Dar es Salaam, Tanzania.

Paschal Mdoe (P)

Haydom Lutheran Hospital, Haydom, Manyara, Tanzania.

Hussein Kidanto (H)

School of Medicine, Aga Khan University, Dar es Salaam, Tanzania.

Hege Ersdal (H)

Department of Anesthesiology and Intensive Care, Stavanger University Hospital, Stavanger, Norway.
Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH